THEOPHYLLINE EXTENDED-RELEASE TA. Key specifications include special_features: LONG ACTION METHOD:EXTENDED RELEASE;, primary_container_type: BOTTLE, primary_container_content_quantity: 500.000 TABLETS, active_medicament_medicinal_strength: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-254-8602, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | LONG ACTION METHOD:EXTENDED RELEASE; |
| primary_container_type | BOTTLE |
| primary_container_content_quantity | 500.000 TABLETS |
| active_medicament_medicinal_strength | 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| NSN | 6505-01-254-8602 |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| SPECIAL FEATURES | LONG ACTION METHOD:EXTENDED RELEASE; |
| PRIMARY CONTAINER TYPE | BOTTLE |